Back to User profile » Dr Barry Schechter

Papers published by Dr Barry Schechter:

Clinical Trial Report

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P

Clinical Ophthalmology 2021, 15:129-140

Published Date: 12 January 2021

Corrigendum

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Tauber J, Schechter BA, Bacharach J, Toyos MM, Smyth-Medina R, Weiss SL, Luchs JI

Clinical Ophthalmology 2019, 13:215-216

Published Date: 24 January 2019

Corrigendum

A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Tauber J, Schechter BA, Bacharach J, Toyos MM, Smyth-Medina R, Weiss SL, Luchs JI

Clinical Ophthalmology 2018, 12:2637-2638

Published Date: 14 December 2018

Original Research

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Tauber J, Schechter BA, Bacharach J, Toyos MM, Smyth-Medina R, Weiss SL, Luchs JI

Clinical Ophthalmology 2018, 12:1921-1929

Published Date: 2 October 2018